AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 29 filers reported holding AGILE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $16,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $18,984,000 | 24.27% |
| CAXTON CORP | 1,623,567 | $6,088,000 | 9.50% |
| Vivo Capital, LLC | 1,513,975 | $5,677,000 | 1.43% |
| Aisling Capital LLC | 1,804,933 | $6,768,000 | 1.16% |
| INVESTOR AB | 3,510,189 | $13,163,000 | 0.92% |
| Cormorant Asset Management, LP | 1,250,000 | $4,688,000 | 0.78% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 430,000 | $1,613,000 | 0.43% |
| PURA VIDA INVESTMENTS, LLC | 174,501 | $654,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 955,109 | $3,582,000 | 0.19% |
| ELEMENT CAPITAL MANAGEMENT LLC | 61,052 | $229,000 | 0.05% |